These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15928265)

  • 41. Adverse drug events in emergency department population: a prospective Italian study.
    Trifirò G; Calogero G; Ippolito FM; Cosentino M; Giuliani R; Conforti A; Venegoni M; Mazzaglia G; Caputi AP
    Pharmacoepidemiol Drug Saf; 2005 May; 14(5):333-40. PubMed ID: 15682429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation and overview of the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance Project (NEISS-CADES).
    Jhung MA; Budnitz DS; Mendelsohn AB; Weidenbach KN; Nelson TD; Pollock DA
    Med Care; 2007 Oct; 45(10 Supl 2):S96-102. PubMed ID: 17909391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A concept-based medication vocabulary: an essential requirement for pharmacy decision support.
    Broverman C; Kapusnik-Uner J; Shalaby J; Sperzel D
    Pharm Pract Manag Q; 1998 Apr; 18(1):1-20. PubMed ID: 10184876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving adverse drug event detection in critically ill patients through screening intensive care unit transfer summaries.
    Anthes AM; Harinstein LM; Smithburger PL; Seybert AL; Kane-Gill SL
    Pharmacoepidemiol Drug Saf; 2013 May; 22(5):510-6. PubMed ID: 23440931
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reliability evaluation of the adapted national coordinating council medication error reporting and prevention (NCC MERP) index.
    Snyder RA; Abarca J; Meza JL; Rothschild JM; Rizos A; Bates DW
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):1006-13. PubMed ID: 17523185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers.
    Shin YS; Lee YW; Choi YH; Park B; Jee YK; Choi SK; Kim EG; Park JW; Hong CS
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):910-5. PubMed ID: 19621345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Adverse Drug Event Collaborative: a joint venture to measure medication-related patient harm.
    Seddon ME; Jackson A; Cameron C; Young ML; Escott L; Maharaj A; Miller N
    N Z Med J; 2012 Jan; 126(1368):9-20. PubMed ID: 23385830
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence and preventability of adverse drug events in hospitalized adults.
    Bates DW; Leape LL; Petrycki S
    J Gen Intern Med; 1993 Jun; 8(6):289-94. PubMed ID: 8320571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.
    Bates DW; Cullen DJ; Laird N; Petersen LA; Small SD; Servi D; Laffel G; Sweitzer BJ; Shea BF; Hallisey R
    JAMA; 1995 Jul; 274(1):29-34. PubMed ID: 7791255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
    Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
    Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.
    Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R
    Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of an active on-ward participation of hospital pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients: protocol of the WINGS study (Ward-oriented pharmacy in newly admitted geriatric seniors).
    Klopotowska JE; Wierenga PC; de Rooij SE; Stuijt CC; Arisz L; Kuks PF; Dijkgraaf MG; Lie-A-Huen L; Smorenburg SM;
    BMC Health Serv Res; 2011 May; 11():124. PubMed ID: 21612624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.
    Hébert G; Netzer F; Ferrua M; Ducreux M; Lemare F; Minvielle E
    Eur J Cancer; 2015 Feb; 51(3):427-35. PubMed ID: 25549531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adverse occurrences during hospitalization on a general medicine service.
    Nettleman MD; Nelson AP
    Clin Perform Qual Health Care; 1994; 2(2):67-72. PubMed ID: 10139986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and preventability of adverse drug events in a teaching hospital: a cross-sectional study.
    Benkirane R; Pariente A; Achour S; Ouammi L; Azzouzi A; Soulaymani R
    East Mediterr Health J; 2009; 15(5):1145-55. PubMed ID: 20214128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pediatric drug surveillance and the Food and Drug Administration's adverse event reporting system: an overview of reports, 2003-2007.
    Johann-Liang R; Wyeth J; Chen M; Cope JU
    Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):24-7. PubMed ID: 19009550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Capability of hospital computer systems in performing drug-use evaluations and adverse drug event monitoring.
    Grasela TH; Walawander CA; Kennedy DL; Jolson HM
    Am J Hosp Pharm; 1993 Sep; 50(9):1889-95. PubMed ID: 8135235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medication reconciliation for reducing drug-discrepancy adverse events.
    Boockvar KS; Carlson LaCorte H; Giambanco V; Fridman B; Siu A
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):236-43. PubMed ID: 17062324
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk factors for hospital admissions associated with adverse drug events.
    Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
    Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive value of alert triggers for identification of developing adverse drug events.
    Moore C; Li J; Hung CC; Downs J; Nebeker JR
    J Patient Saf; 2009 Dec; 5(4):223-8. PubMed ID: 22130215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.